FDA panel votes 3-14 that Abbott (ABT) has not found right Humira dose

August 28, 2012 1:31 PM EDT Send to a Friend
FDA panel votes 3-14 that Abbott (NYSE: ABT) has not found right Humira dose.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, General News

Add Your Comment